CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.32% | 5.00% | 10.23% | 12.02% | 14.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.32% | 5.00% | 10.23% | 12.02% | 14.83% |
| Cost of Revenue | 2.36% | 2.61% | 6.70% | 8.71% | 12.26% |
| Gross Profit | 5.88% | 6.94% | 13.18% | 14.79% | 16.97% |
| SG&A Expenses | 4.68% | 2.59% | 6.41% | 7.11% | 11.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.31% | 2.64% | 6.67% | 7.85% | 11.60% |
| Operating Income | 12.57% | 25.55% | 47.86% | 59.67% | 50.61% |
| Income Before Tax | 39.96% | 101.70% | 440.63% | 394.82% | 220.89% |
| Income Tax Expenses | 23.66% | 86.96% | 199.88% | 140.01% | 172.44% |
| Earnings from Continuing Operations | 44.20% | 105.44% | 127.25% | 11.68% | 187.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.20% | 105.44% | 127.25% | 11.68% | 187.85% |
| EBIT | 12.57% | 25.55% | 47.86% | 59.67% | 50.61% |
| EBITDA | 8.50% | 16.65% | 28.73% | 34.48% | 29.97% |
| EPS Basic | 43.61% | 104.60% | 125.66% | 10.69% | 183.55% |
| Normalized Basic EPS | 20.23% | 39.13% | 82.53% | 102.10% | 90.19% |
| EPS Diluted | 45.55% | 107.80% | 126.86% | 10.75% | 180.44% |
| Normalized Diluted EPS | 22.46% | 41.78% | 85.28% | 103.31% | 87.77% |
| Average Basic Shares Outstanding | 0.51% | 0.57% | 0.66% | 0.79% | 1.40% |
| Average Diluted Shares Outstanding | -1.38% | -1.23% | -0.50% | 0.43% | 2.64% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.30% | -0.51% | -0.56% | -0.10% | 2.16% |